ArTS Archivio della ricerca di Trieste

SAVA, GIANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.369
EU - Europa 11.361
AS - Asia 10.517
SA - Sud America 1.167
AF - Africa 260
Continente sconosciuto - Info sul continente non disponibili 32
OC - Oceania 19
Totale 46.725
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.173
SG - Singapore 4.027
CN - Cina 2.704
UA - Ucraina 1.918
SE - Svezia 1.874
PL - Polonia 1.468
DE - Germania 1.288
IT - Italia 1.139
HK - Hong Kong 1.079
BR - Brasile 933
VN - Vietnam 923
KR - Corea 726
FI - Finlandia 704
RU - Federazione Russa 693
GB - Regno Unito 635
FR - Francia 570
TR - Turchia 379
BG - Bulgaria 308
IE - Irlanda 301
IN - India 156
NL - Olanda 154
CA - Canada 91
AR - Argentina 89
MA - Marocco 81
BD - Bangladesh 72
IQ - Iraq 60
MX - Messico 60
CH - Svizzera 57
SA - Arabia Saudita 51
JP - Giappone 49
ID - Indonesia 46
ES - Italia 40
ZA - Sudafrica 40
BE - Belgio 33
EU - Europa 30
PK - Pakistan 30
AT - Austria 29
EC - Ecuador 29
SN - Senegal 28
KE - Kenya 26
UZ - Uzbekistan 26
VE - Venezuela 25
RO - Romania 24
CO - Colombia 23
EG - Egitto 23
TH - Thailandia 23
CL - Cile 20
PH - Filippine 20
PY - Paraguay 18
TW - Taiwan 15
BA - Bosnia-Erzegovina 14
CZ - Repubblica Ceca 14
MY - Malesia 14
PT - Portogallo 14
AE - Emirati Arabi Uniti 13
KZ - Kazakistan 13
DK - Danimarca 12
JO - Giordania 12
LT - Lituania 12
RS - Serbia 12
TN - Tunisia 12
BO - Bolivia 11
DZ - Algeria 11
UY - Uruguay 11
AU - Australia 10
AZ - Azerbaigian 9
IL - Israele 9
IR - Iran 9
AL - Albania 8
GR - Grecia 8
NZ - Nuova Zelanda 8
CI - Costa d'Avorio 7
DO - Repubblica Dominicana 7
GE - Georgia 7
HN - Honduras 7
NP - Nepal 7
ET - Etiopia 6
HR - Croazia 6
HU - Ungheria 6
JM - Giamaica 6
NG - Nigeria 6
OM - Oman 6
PE - Perù 6
TT - Trinidad e Tobago 6
LB - Libano 5
QA - Qatar 5
SI - Slovenia 5
BB - Barbados 4
BH - Bahrain 4
GA - Gabon 4
CR - Costa Rica 3
GT - Guatemala 3
LK - Sri Lanka 3
MD - Moldavia 3
NI - Nicaragua 3
PS - Palestinian Territory 3
AO - Angola 2
BW - Botswana 2
BY - Bielorussia 2
CG - Congo 2
Totale 46.682
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.449
Singapore 2.396
Ann Arbor 2.360
Fairfield 1.903
Ashburn 1.742
Houston 1.688
Jacksonville 1.642
Chandler 1.266
Warsaw 1.159
San Jose 1.132
Wilmington 1.111
Hong Kong 1.054
Seattle 831
Hefei 799
Seoul 711
Cambridge 647
Beijing 630
Princeton 574
Boardman 477
Chicago 458
Sofia 307
Dublin 297
Ho Chi Minh City 292
Columbus 291
Zgierz 281
Izmir 277
Los Angeles 266
Lauterbourg 261
Santa Clara 236
Moscow 230
The Dalles 219
Dearborn 217
Hanoi 217
Dallas 214
Buffalo 177
Trieste 176
Milan 151
San Diego 136
Helsinki 114
Düsseldorf 109
London 80
Frankfurt am Main 74
Munich 68
São Paulo 67
Casablanca 58
New York 57
Falls Church 54
Guangzhou 53
Verona 53
Kocaeli 51
Council Bluffs 50
Phoenix 49
Norwalk 47
Amsterdam 46
Redwood City 46
Kunming 45
Bern 43
Orem 43
Shanghai 43
Da Nang 42
Nanjing 42
Bremen 41
Mestre 39
Rio de Janeiro 39
Tokyo 39
Turku 38
Salt Lake City 37
Des Moines 35
Jinan 33
Tianjin 33
Haiphong 32
Brussels 29
Chennai 28
Dakar 28
Denver 25
San Francisco 25
Hangzhou 23
Nairobi 23
North Bergen 23
Tashkent 23
Brooklyn 22
Montreal 22
Poplar 22
Porto Alegre 22
Zhengzhou 21
Johannesburg 20
Miano 20
Redondo Beach 20
Andover 19
Elk Grove Village 19
Jeddah 19
Tampa 19
Vienna 19
Baghdad 18
Belo Horizonte 18
Fuzhou 18
Manchester 18
Nuremberg 18
Atlanta 17
Brasília 17
Totale 31.589
Salva come PNG Salva come JPEG
Nome #
The differential distribution of RAPTA-T in non-invasive and invasive breast cancer cells correlates with its anti-invasive and anti-metastatic effects 642
Effects of Two Fullerene Derivatives on Monocytes and Macrophages 471
Colorectal Cancer Metastases Settle in the Hepatic Microenvironment Through α5β1 Integrin 397
Identification and Characterization of a Novel Family of Cysteine-Rich Peptides (MgCRP-I) from Mytilus galloprovincialis 369
Pharmacological activities of ruthenium complexes related to their NO scavenging properties 342
Chemical and Molecular Approach to Tumor Metastases 341
A Cationic [60] Fullerene Derivative Reduces Invasion and Migration of HT-29 CRC Cells in Vitro at Dose Free of Significant Effects on Cell Survival 321
Analysis of the cytotoxicity of synthetic antimicrobial peptides on mouse leucocytes: implications for systemic use. 310
Influence of components of tumour microenvironment on the response of HCT-116 colorectal cancer to the ruthenium-based drug NAMI-A 285
New salts of anionic complexes of Ru(III) as antimetastatic and antineoplastic agents. 275
Complessi dicarbossilati del rutenio(II) e loro impiego come antitumorali 255
Sulfoxide ruthenium complexes: non toxic tools for the selective treatment of solid tumour metastases. 246
Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy 244
Can peptides be orally-delivered in crustaceans? The case study of the Crustacean Hyperglycaemic Hormone in Procambarus clarkii 244
A novel retinoic/butyric hyaluronan ester for the treatment of acute promyelocytic leukemia: preliminary preclinical results 241
Antitumor action of mer-trichlorobis(dimethyl sulfoxide)aminoruthenium(III) (BBR2382) in mice bearing Lewis lung carcinoma 240
Chemical, biological and antitumor properties of ruthenium(II) complexes with dimethylsulfoxide 235
Antimetastatic Action and Lymphocyte Activation by the Modified Lysozyme Lyso-M-PEG in Mice with Mca Mammary Carcinoma 235
Antitumor properties of ruthenium(II)-dimethylsulfoxide complexes in the Lewis lung carcinoma system 232
Response of MCa mammary carcinoma to cisplatin and to Na[trans-RuCl4(DMSO)(Im)]. 231
Antineoplastic action of p-(3-methyl-1-triazeno)benzoic acid potassium salt, a monomethyl derivative of the antimetastatic compound DM-COOK 231
Effects of lysozyme on spleen and lungs in mice with Lewis lung carcinoma 227
Influence of the anionic ligands on the anticancer activity of Ru(II)-dmso complexes: Kinetics of aquation and in vitro cytotoxicity of new dicarboxylate compounds in comparison with their chloride precursors 226
The antimetastatic drug NAMI-A potentiates the phenylephrine-induced contraction of aortic smooth muscle cells and induces a transient increase in systolic blood pressure 224
Ruthenium(III) complexes as antineoplastic agents. 223
Antineoplastic activity and toxicity of an organometallic complex of ruthenium(II) in comparison with cis-PDD in mice bearing solid malignant neoplasms 223
Antitumor effects of rhodium(I), iridium(I) and ruthenium(II) complexes in comparison with cis-dichloro-diamminoplatinum(II) in mice bearing Lewis lung carcinoma 223
trans-Ru(II)dimethylsulfoxides: antineoplastic action on mouse tumors 221
Antitumour properties of dimethylsulphoxide ruthenium (II) complexes in theLewis lung carcinoma system. 220
Tumor inhibition and effects on host survival time by rutheniumIII andrhodiumIII complexes with dimethylsulphoxide ligands. 218
Antineoplastic effects of mer-RuCl3(DMSO)2(NH3) against murine tumors: comparison with cisplatin and with ImH[RuIm2Cl4]. 218
Ruthenium-Porphyrin Conjugates with Cytotoxic and Phototoxic Antitumor Activity 217
Antiinflammatory action of hydrosoluble dimethyltriazenes on the carrageenin-induced edema in guinea pigs 217
Antimetastatic action and lymphocyte activation by the modified lysozyme mPEG-Lyso in mice with MCa mammary carcinoma 217
RNA-seq analysis of the whole transcriptome of MDA-MB-231 mammary carcinoma cells exposed to the antimetastatic drug NAMI-A 217
Reconsidering clinical pharmacology frameworks as a necessary strategy for improving the health care of patients: a systematic review 217
Antitumor and antimetastatic effects of benzenoid triazenes in mice bearing Lewis lung carcinoma. 213
Antileukemic action of RuCl2(DMSO)4 isomers and prevention of brain involvement on P388 leukemia and on P388/DDP subline 212
Reduction of lung metastases by Na[trans-RuCl4(DMSO)Im] is not coupled with the induction of chemical xenogenization 211
Antimetastatic action and toxicity on healty tissues of Na[trans-RuCl4(DMSO)Im] in the mouse. 210
Actin-dependent tumour cell adhesion after short-term exposure to the antimetastasis ruthenium complex NAMI-A 209
Efficacy of 5-FU combined to Na[trans-RuCl4(DMSO)(Im)], a novel selective antimetastatic agent, on the survival time of mice with P388 leukemia, P388/DDP subline and MCa mammary carcinoma 208
Complessi di Rutenio con elevata attività antitumorale 208
Age Dependent Modification of the Metabolic Profile of the Tibialis Anterior Muscle Fibers in C57BL/6J Mice 207
Complessi trans di rutenio come agenti antineoplastici 205
Orally administered microencapsulated lysozyme downregulates serum AGE and reduces the severity of early-stage diabetic nephropathy 205
Biochemical and biological characteristics of leucocyte proteinase inhibitors. 204
Free exchange across cells,and echistatin-sensitive membrane target for the metastasis inhibitor NAMI-A(imidazolium trans-imidazole dimethyl sulfoxide tetrachlororuthenate)ON KB Tumor cells. 202
Antimetastatic action of the prostacyclin analog Iloprost in the mouse 202
Antimetastatic properties and DNA interactions of the novel class of dimeric Ru(III) compounds Na2[{trans-RuCl4(Me2SO)}2(μ-L)] (L=ditopic, non-chelating aromatic N-ligand). A preliminary investigation 200
Dual action of NAMI-A in inhibition of solid tumor metastasis: Selective targeting of metastatic cells and binding to collagen 200
Antimetastatic effects of N-diazoacetyl-glycine derivatives in C57BL mice. 200
Hydrophilic polymer coated monodispersed Fe3O4 nanostructures and their cytotoxicity 200
Rhodium(III) analogues of antitumour-active ruthenium(III) compounds: the crystal structure of [ImH][trans-RhCl4(Im)2] (Im= imidazole) 199
Effects of antimetastatic, antiinvasive and cytotoxic agents on the growth and spread of transplantable leukemias in mice. 199
Antimetastatic action and toxicity on healthy tissues ofNa[trans-RuCl4(DMSO)Im] in the mouse. 198
The mechanism of tumour cell death by metal-based anticancer drugs is not only a matter of DNA interactions 198
The development of tumor-inhibiting ruthenium dimethylsulfoxide complexes 197
Antimetastatic effects and tumor proteinase inhibition by spleen intracellular inhibitors of neutral proteinases. 197
Effects of L-(adamant-2-yl)glycyl-L-alanyl-D-isoglutamine on the antitumor action of cyclophosphamide, 5-FU, cisplatin and dacarbazine on advanced carcinomas of the mouse 195
In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes 194
Study of a potential drug delivery system based on carbon nanoparticles: Effects of fullerene derivatives in MCF7 mammary carcinoma cells 194
Effects of endotoxin in mice bearing solid metastasizing tumors and treated with lysozyme hydrochloride 194
Microcapsule a doppio strato di polisaccaridiutilizzabili come veicoli per la somministrazione oraledi sostanze biologicamente attive 193
Antineoplastic action of egg-white lysozyme on the growth of MCa mammary carcinoma and TLX5 lymphoma in the CBA mouse. 193
A review on usnic acid, an interesting natural compound 193
Effects of an inducer and an inhibitor of hepatic metabolism on the antitumor action of dimethyltriazenes 193
Inhibition of adhesion, migration and of α5β1 integrin in the HCT-116 colorectal cancer cells treated with the ruthenium drug NAMI-A 193
Influence of chemical stability on the activity of the antimetastasis ruthenium compound NAMI-A 192
Ruthenium complexes can target determinants of tumour malignancy 191
Methodologic problems encountered in the assay of proteinases in Lewis lung carcinoma, a mouse metastasizing tumor. 191
Effects of trans-RuCl2 (DMSO)4 on B16 melanoma in mice. 190
Tuning the hydrophobicity of ruthenium(ii)-arene (RAPTA) drugs to modify uptake, biomolecular interactions and efficacy 190
Antineoplastic action of p-(3-methyl-1-triazeno) benzoic acid potassium salt, monomethylderivative of the antimetastatic compound DM-COOK 190
Na[trans-RuCl4(DMSO)(Im)]*2DMSO - antimetastatic ruthenium agent 190
Human recombinant lysozyme downregulates advanced glycan endproduct-induced interleukin-6 production and release in an in vitro model of human proximal tubular epithelial cells 190
Inhibition of B16 Melanoma Metastases with the Ruthenium Complex Imidazolium trans-Imidazoledimethylsulfoxide-tetrachlororuthenate and Down-Regulation of Tumor Cell Invasion. 189
Antiviral properties and cytotoxic activity of platinum(II) complexes with 1,10-phenanthrolines and acyclovir or penciclovir 189
Antitumor effects of GANU and other nitrosourea derivatives against transplantable leukemias and solid tumors in mice. 189
A kinetic study of the chemical stability of the antimetastatic ruthenium complex NAMI-A. 186
Anticancer ruthenium complexes 186
Distinct effects of dinuclear ruthenium(III) complexes on cell proliferation and on cell cycle regulation in human and murine tumor cell lines. 185
Down-regulation of tumour gelatinase/inhibitor balance and preservation of tumour endothelium by an antimetastatic ruthenium complex 185
Investigation on the oxidative N-demethylation of aryltriazenes in vitro 185
Chemical, biological and antitumor properties of ruthenium-dimethylsulfoxide complexes 184
Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs 184
Features and full reversibility of the renal toxicity of the ruthenium-based drug NAMI-A in mice 184
Effects of NAMI-A and some related ruthenium complexes on cell viability after short exposure of tumor cells. 183
Profiling the molecular mechanism of fullerene cytotoxicity on tumor cells by RNA-seq 183
Influence of the binding of reduced NAMI-A to human serum albumin on the pharmacokinetics and biological activity 183
Biological and technological evaluation of PVC containers for human blood and blood components 182
Antiangiogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengers 181
Reduction of B16 melanoma metastases by oral administration of egg-white lysozyme 181
In vivo tumour and metastasis reduction and in vitro effects on invasion assays of the ruthenium RM175 and osmium AFAP51 organometallics in the mammary cancer model 181
Stimulation of GALT and Activation of Mesenteric Lymphonode Lymphocytes by a Modifìed Iysozyme in CBA Mice with Mca mammary carcinoma 180
Antitumor action of rhodium(I) and iridium(I) complexes 180
Synthesis and characterization of a diruthenium(II,III)-ketoprofen compound and study of the in vitro effects on CRC cells in comparison to the naproxen and ibuprofen derivatives 180
Metal-Based Inhibition of Poly(ADP-ribose) Polymerase - The Guardian Angel of DNA 179
Antitumor effect of some rhodium(I) derivatives on MCa mammary carcinoma 179
Long-term resveratrol treatment improves the capillarization in the skeletal muscles of ageing C57BL/6J mice 179
Totale 22.042
Salva come PNG Salva come JPEG
Categoria #
all - tutte 133.689
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 133.689
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.072 0 0 0 0 0 0 0 0 0 490 136 446
2021/20223.230 103 253 187 463 49 257 137 116 386 345 200 734
2022/20233.888 426 429 284 486 445 737 9 354 474 23 158 63
2023/20241.932 163 134 109 112 221 92 245 504 29 35 141 147
2024/20255.277 96 157 510 422 495 511 430 310 720 559 441 626
2025/202611.928 1.275 830 1.086 1.082 1.082 1.316 2.023 454 1.381 1.399 0 0
Totale 47.430